Abstract
Menopause is the permanent cessation of menses. In the United States, the mean age at menopause is approximately 51 years, with the majority of women experiencing menopause at 45 to 55 years of age. The age at which menopause occurs has not altered substantially since the first available records, which placed it at 50 years in medieval Europe. The major change has been that, with increasing longevity, women now live approximately a third of their total life span after menopause. Menstruation beyond age 55 years increases the possibility of endometrial hyperplasia and/or malignancy and requires that an endometrial biopsy be performed. The age at menopause is not altered by use of oral contraceptives, age at or number of pregnancies, age at menarche, race, body habitus, or socioeconomic conditions. The major environmental factor altering the age at onset of menopause is cigarette smoking, which causes, menopause to occur 1 to 2 years earlier than might be predicted. The hormonal basis of menopause is decreased ovarian steroidogenesis, which occurs in the face of adequate gonadotropin stimulation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Borner E. The menopause. In: Cyclopaedia of Obstetrics and Gynecology. New York, NY: William Wood; 1887.
Budoff PW. No More Hot Flashes and Other Good News. New York; NY: GP Putnam’s Sons; 1983.
Cutler WB, Garcia CR, Edwards DA. Menopause: A guide for Women and the Men Who Love Them. New York; NY: Norton; 1983.
Haney AF. The ‘physiology’ of the climacterium. Clin Obstet Gynecol 1986; 29: 397–405.
Jick H, Porter J, Morrison AS. Relation between smoking and age of natural menopause: report from Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet 1977; 1: 1354–1356.
Judd HL, Davidson BJ, Frumar AM, et al. Serum androgens and estrogens in postmenopausal women with and without endometrial cancer. Am J Obstet 1980; 136: 859–871.
Sherman BM, West JH, Korenman SG. The menopausal transition: analysis of LH, FSH, estradiol and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 1976; 42: 629–636.
Kohler PO, Ross GT, Odell WD. Metabolic clearance and production rates of human luteinizing hormone in pre-and post-menopausal women. J Clin Invest 1968; 43: 381–388.
Scaglia H, Medina M, Pinto-Ferreira Al, et al. Pituitary LH and FSH section and responsiveness in women of old age. Acta Endocrinol 1976; 81: 673–679.
Petraglia A, Porro C, Facchinetti F, et al. Opioid control of LH secretion in humans: menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine. Life Sci 1986; 38: 2103–2110.
Melis GB, Cagnacci A, Gambacciani M, et al. Chronic bromocriptine administration restores luteinizing hormone response to naloxone in post-menopausal women. Neuroendocrinology 1988; 47: 159–163.
Mishell DR, Jr, Brenner PF. Menopause. In: Mishell DR, Jr, Davajan V, eds. Infertility, Contraception, and Reproductive Endocrinology. 2nd ed. Oradell, NJ: Medical Economics Books; 1986: 179–202.
Erik Y, Meldrum DR, Judd HL. Estrogen levels in post-menopausal women with hot flashes. Obstet Gynecol 1982; 59: 403–411.
Kronenberg M, Carraway RE. Changes in neurotensinlike immunoreactivity during menopausal hot flashes. J Clin Endocrinol Metab 1985; 60: 1081–1086.
Jaffe RB. The menopausal and perimenopausal period. In: Yen SSC, Jaffe RB, eds. Reproductive Endocrinology. Philadelphia, Pa: WB Saunders Co; 1986.
Tataryn IV, Meldrum DR, Lu LH, et al. LH, FSH, and skin temperature during the menopausal hot flash. J Clin Endocrinol Metab 1979; 49: 152–158.
Svenson TH. Clonidine treatment in vegetative dysfunction: experimental reationales. Acta Obstet Gynecol Scand Suppl 1985; 132: 23–28.
Hammar M, Berg G. Clonidine in the treatment of menopausal flushing. Acta Obstet Gynecol Scand Suppl 1985; 132: 29–31.
Cox B, Lee TF. Further evidence for a physiological role for hypothalamic dopamine in thermoregulation in the rat. J Physiol 1980; 300: 7–12.
David A, Don R, Tajchner G, et al. Veralipride: alternative antidopaminergic treatmtne for menopausal symptoms. Am J Obstet Gynecol 1988; 158: 1107–1115.
Paterson MEL. Randomized double-blind crossover trial into the effect of norethisterone on climateric symptoms and biochemical profile. Br J Obstet Gynecol 1982; 89: 464–472.
Laufer LR, Erlik Y, Meldrum DR, et al. Effect of chlonidine on hot flashes in postmenopausal women. Obstet Gynecol 1982; 60: 583–586.
Lightman SL, Jacobs HS. Naloxone suppresses menopausal hot flushes. Lancet 1979; 2: 1071–1074.
Campbell S. Double-blind psychometric studies on the effects of natural estrogens on post-menopausal women. In: Campbell S, ed. Management of the Menopause and Post-Menopausal Years. Lancaster, England: MTP Press Ltd; 1976: 152–163.
Strathy JH, Coulam CB, Spelsburg TC. Comparison of estrogen receptors in human premenopausal and postmenopausal uteri: indication of biologically inactive receptor in postmenopausal uteri. Am J Obstet Gynecol 1982; 142: 372–376.
Greenwood S. Hysterectomy and ovarian removal: a major health issue in the perimenopausal years. West J Med 1988; 149: 771–772.
Kikku P, Gronroos M, Hirvonen T, et al. Supravaginal uterine amputation vs. hysterectomy: effects on libido and orgasm. Acta Obstet Gynecol Scand 1983; 62: 147–152.
Shearer MR, Shearer ML. Sexuality and sexual counseling in the elderly. Clin Obstet Gynecol 1977; 20: 197–208.
Masters W, Johnson V. Human sexual response. Boston; Mass: Little Brown & Co Inc, 1970.
Garde K, Lunde I. Female sexual behavior in a random sample of 40-year-old women. Maturitas 1980; 2: 225–240.
Osborn M, Hawton K, Gath D. Sexual dysfunction among middle-aged women in the communuity. Bri Med J 1988; 296: 959–962.
McCoy NL, Davidson JM. A longitudinal study of the effects of menopause on sexuality. Maturitas 1985; 7: 203–210.
Starr BD, Weiner MB. On Sex and Sexuality in the Mature Years. New York; NY: Stein & Day Publishers, 1981.
Kinsey AC, Pomeroy WB, Martin CE. Sexual Behavior in the Human Female. Philadelphia, Pa: WB Saunders; 1953.
Newman G, Nichols CR. Sexual activities and attitudes in older persons. JAMA 1960; 173: 33–35.
Bretschneider JG, McCoy NL. Sexual interest and behavior in helathy 80- to 102-year-olds. Arch Sex Behav 1988; 17: 109–129.
Persson G. Sexuality in a 70-year-old urban population. J Psychosom Res 1980; 24: 137–154.
Salmon TJ, Geist SH. Effect of androgens on libido in women. J Clin Endocrinol Metab 1943; 3: 235–238.
Studd JWW, Collins WP, Charkrvati S. Oestradiol and testosterone implants in the treatment of psychosexual problems in the postmenopausal women. Br J Obstet Gynaecol 1977; 84: 314–316.
Adelman M. Long Time Passing: Lives of Older Lesbians. Boston; Mass: Alyson Publications Inc; 1986.
Davis LJ. Rape and older women. In: Warner CG, ed. Rape and Sexual Assault Management and Intervention. Rockville, Md: Aspen Publishers; 1980: 94–118.
Ross RK, Paganini-Hill A, Mack TM. Menopausal oestrogen therapy and protection from death from ischemic disease. Lancet 1981; 1: 858–862.
Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and non-contraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987; 75: 1102–1109.
Colditz GA, Willett WC, Stampfer MJ, et al. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987; 316: 1105–1110.
Ottosson UB, Carlstrom K, Johansson BG, et al. Estrogen induction of liver proteins and high-density liporpotein cholesterol: comparison between estradiol vale-nate and ethinyl estradiol. Gynecol Obstet Invest 1986; 22: 198–205.
Farish E, Fletcher CD, Hart DM et al. The effects of conjugated equine oestrogens with and without a cyclical progestogen on lipoproteins and HDL subfractions in postmenopausal women. Acta Endocrinol 1986; 113: 123–127.
Collins J, Donner A, Allen LH, et al. Oestrogen use and survival in endometrial cancer. Lancet 1980; 2: 961–963.
Varma TR. Effect of long-term therapy with estrogen and progesterone on endometrium of postmenopausal women. Acta Obstet Gynecol Scand 1985; 64: 41–46.
Wingo PA, Layde PM, Lee NC, et al. The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy. JAMA 1987; 257: 209–215.
Boston Collaborative Drug Project: Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. N Engl J Med 1974; 290: 15–19.
Barrett-Connor E. Postmenopausal estrogens: current prescribing patterns of San Diego gynecologists. West J Med 1986; 144: 620–621.
Hammond CB, Jelovsek FR, Lee KL, et al. Effects of long-term estrogen replacement therapy, I: metabolic. Am J Obstet Gynecol 1979; 133: 525–536.
Nachtigall L, Nachtigall RH, Nachtigall RD, et al. Estrogen replacement, II: a prospective study in the relationship t carcinoma and cardiovascular and metabolic problems. Obstet Gynecol 1979; 54: 74–79.
Gambrell RD Jr, Castaneda TA, Ricci CA. Management of postmenopausal bleeding to prevent endometrial cancer. Maturitas 1978; 1: 99–106.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kaiser, F.E., Morley, J.E. (1990). The Menopause and Beyond. In: Cassel, C.K., Riesenberg, D.E., Sorensen, L.B., Walsh, J.R. (eds) Geriatric Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-2093-8_22
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2093-8_22
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-2095-2
Online ISBN: 978-1-4757-2093-8
eBook Packages: Springer Book Archive